China's Monkeys: The Unseen Bottleneck in Biotech Innovation China's pharmaceutical industry has been dealt a significant blow with the recent surge in prices of lab monkeys, but this development is not unexpected.
Behind the scenes of China's thriving biotech sector lies a complex web of supply and demand that threatens to slow down the country's progress in innovative drug development.
The regulated breeding farms are holding steady, so what's driving the price increase? The answer lies in the explosive growth of biotech research in China.